Global Custom Market Research Reports Provider Company

phone

Abivax SA (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 36
  • Category: Pharmaceuticals
  • Country: France
Summary

Abivax SA (Abivax) is a biotechnology company that researches, develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases. The companys pipeline products comprise ABX464, a small molecule against HIV; ABX311 for chikungunya; ABX544 to treat EBOLA virus infection; and ABX196, an immune enhancer candidate for vaccination. The company leverages three technology platforms for drug discovery antiviral, immune enhancing and polyclonal antibodies. It has collaborations with research institutions, cancer agencies, universities and other drug developers. Abivax is headquartered in Paris, France.

Abivax SA (ABVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 4
List of Figures 4
Abivax SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abivax SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abivax SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abivax SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abivax SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abivax SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Evotec and Abivax Enter into Partnership 10
ABIVAX Enters into Co-Marketing Agreement with Finlay Institute 11
Licensing Agreements 12
ExpreS2ion Biotech to Enter into Licensing Agreement with Abivax 12
Heber Biotec Enters Into Licensing Agreement with Abivax 13
ABIVAX Enters into Licensing Agreement with CIGB for ABX203 14
Equity Offering 15
Abivax to Raise USD14 Million in Public Offering of Shares 15
Abivax Raises USD65 Million in IPO 16
Abivax SA - Key Competitors 17
Abivax SA - Key Employees 18
Abivax SA - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Mar 16, 2018: ABIVAX: 2017 Full-Year Results and Progress Report 20
Sep 20, 2017: ABIVAX First-Half 2017 Financial Results and Update 24
Mar 15, 2017: ABIVAX Announces 2016 Full-Year Results and Progress Report 27
Corporate Communications 30
Jan 29, 2018: ABIVAX Names Carol L. Brosgart As Board Director 30
Oct 05, 2017: ABIVAX expands Scientific Advisory Board with appointment of renowned virologist and former President of the Pasteur Institute, Prof. Christian Brechot 31
Government and Public Interest 32
Jan 09, 2017: ABIVAX to receive 8.4 million from Bpifrance Invest in the Future Program (PIA) for the development of innovative antiviral drugs 32
Product News 33
Feb 23, 2017: ABIVAX Has Discovered Novel Antiviral Molecules with Potential for Dengue Virus Treatment 33
Clinical Trials 34
Apr 04, 2017: ABIVAX initiates clinical trial (ABX464-005) to evaluate the effect of ABX464 on HIV-reservoirs in HIV Patients 34
Feb 02, 2017: Phase I Clinical Data of ABX464, ABIVAXs First-in-Class anti-HIV Drug, Published in Two Articles in Peer-Reviewed Journals 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List Of Tables

List of Tables
Abivax SA, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Abivax SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abivax SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abivax SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abivax SA, Deals By Therapy Area, 2012 to YTD 2018 8
Abivax SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Evotec and Abivax Enter into Partnership 10
ABIVAX Enters into Co-Marketing Agreement with Finlay Institute 11
ExpreS2ion Biotech to Enter into Licensing Agreement with Abivax 12
Heber Biotec Enters Into Licensing Agreement with Abivax 13
ABIVAX Enters into Licensing Agreement with CIGB for ABX203 14
Abivax to Raise USD14 Million in Public Offering of Shares 15
Abivax Raises USD65 Million in IPO 16
Abivax SA, Key Competitors 17
Abivax SA, Key Employees 18
Abivax SA, Other Locations 19

List Of Figures

List of Figures
Abivax SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abivax SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abivax SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abivax SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abivax SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abivax SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abivax SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abivax SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from

View Report

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandards product portfolio

View Report

Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports